UK markets close in 3 hours 23 minutes

Carisma Therapeutics, Inc. (W2J.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.4690-0.0500 (-3.29%)
As of 09:59AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
14,919
14,919
9,834
0
0
Operating expenses
Research development
74,125
74,125
56,618
34,387
23,292
Selling general and administrative
29,525
29,525
9,378
6,407
5,086
Total operating expenses
103,650
103,650
65,996
40,794
28,378
Operating income or loss
-88,731
-88,731
-56,162
-40,794
-28,378
Interest expense
-
-
3,145
-
-
Total other income/expenses net
-84
-84
-1,919
-
-
Income before tax
-86,879
-86,879
-61,226
-40,784
-28,349
Income from continuing operations
-86,879
-86,879
-61,226
-40,784
-28,349
Net income
-86,879
-86,879
-61,226
-40,784
-28,349
Net income available to common shareholders
-86,879
-86,879
-61,226
-40,784
-28,349
Basic EPS
-1.21
-2.59
-1.52
-1.01
-0.70
Diluted EPS
-1.21
-2.59
-1.52
-1.01
-0.70
Basic average shares
40,255
33,524
40,255
40,255
40,255
Diluted average shares
40,255
33,524
40,255
40,255
40,255